Araki H, Peck R C, Lefer A M
Arch Int Pharmacodyn Ther. 1981 Jan;249(1):116-25.
The effect of chlorpromazine (CPZ) and mepacrine on hypoxic liver cell damage was studied using an isolated perfused cat liver preparation. High concentrations of CPZ (10(-4) M) significantly augmented the hypoxic leakage of the lysosomal enzyme, cathepsin D, and the cytoplasmic enzyme, lactate dehydrogenase (LDH) into the perfusate. The per cent free cathepsin D activity of hepatic tissue was significantly higher in the 10(-4) M CPZ treated groups (87%) than in the vehicle group (65%). CPZ at a concentration of 10(-6) M also possessed a detrimental effect on hypoxic liver integrity but to a lesser extent compared to 10(-4) M. In contrast, low concentrations of CPZ (10(-7) M) showed a protective effect during hypoxia (i.e., significantly lower perfusate cathepsin D activity and per cent free cathepsin D activity) compared to livers receiving only the vehicle. Mepacrine, another phospholipase A2 inhibitor, showed no significant effect on hypoxic liver damage at concentration of 10(-6) and 5 x 10(-5) M. CPZ has a biphasic action on liver integrity during hypoxia, low concentrations being protective and high concentrations are deleterious. Mepacrine had no significant effect in the hypoxic liver.
使用离体灌注猫肝制备模型研究了氯丙嗪(CPZ)和米帕林对缺氧肝细胞损伤的影响。高浓度的CPZ(10⁻⁴M)显著增加了溶酶体酶组织蛋白酶D和细胞质酶乳酸脱氢酶(LDH)向灌注液中的缺氧渗漏。在10⁻⁴M CPZ处理组中,肝组织中游离组织蛋白酶D的活性百分比(87%)显著高于溶剂对照组(65%)。浓度为10⁻⁶M的CPZ对缺氧肝脏的完整性也有损害作用,但程度小于10⁻⁴M组。相比之下,低浓度的CPZ(10⁻⁷M)在缺氧期间表现出保护作用(即灌注液中组织蛋白酶D的活性和游离组织蛋白酶D的活性百分比显著降低),与仅接受溶剂的肝脏相比。另一种磷脂酶A2抑制剂米帕林在浓度为10⁻⁶M和5×10⁻⁵M时对缺氧肝脏损伤无显著影响。CPZ在缺氧期间对肝脏完整性具有双相作用,低浓度具有保护作用,高浓度具有有害作用。米帕林对缺氧肝脏无显著影响。